These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2492609)

  • 1. Physical properties of the Creutzfeldt-Jakob disease agent.
    Sklaviadis TK; Manuelidis L; Manuelidis EE
    J Virol; 1989 Mar; 63(3):1212-22. PubMed ID: 2492609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Creutzfeldt-Jakob disease infectious fractions by gel permeation chromatography and sedimentation field flow fractionation.
    Sklaviadis T; Dreyer R; Manuelidis L
    Virus Res; 1992 Dec; 26(3):241-54. PubMed ID: 1492497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclease treatment results in high specific purification of Creutzfeldt-Jakob disease infectivity with a density characteristic of nucleic acid-protein complexes.
    Sklaviadis T; Akowitz A; Manuelidis EE; Manuelidis L
    Arch Virol; 1990; 112(3-4):215-28. PubMed ID: 1974131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Creutzfeld-Jakob disease: recent advances; biology of unconventional viruses (author's transl)].
    Cathala F; Moreau-Dubois MC; Brown P
    Pathol Biol (Paris); 1980 Oct; 28(8):545-53. PubMed ID: 6776473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protected endogenous retroviral sequences copurify with infectivity in experimental Creutzfeldt-Jakob disease.
    Akowitz A; Manuelidis EE; Manuelidis L
    Arch Virol; 1993; 130(3-4):301-16. PubMed ID: 8517790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of the subacute spongiform virus encephalopathies of man: kuru and Creutzfeldt-Jakob disease.
    Gibbs CJ; Gajdusek DC
    J Clin Pathol Suppl (R Coll Pathol); 1972; 6():84-96. PubMed ID: 4218244
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Survival of Creutzfeldt-Jakob-disease virus in formol-fixed brain tissue.
    Gajdusek DC; Gibbs CJ
    N Engl J Med; 1976 Mar; 294(10):553. PubMed ID: 814460
    [No Abstract]   [Full Text] [Related]  

  • 8. Nuclease-resistant polyadenylated RNAs of significant size are detected by PCR in highly purified Creutzfeldt-Jakob disease preparations.
    Akowitz A; Sklaviadis T; Manuelidis EE; Manuelidis L
    Microb Pathog; 1990 Jul; 9(1):33-45. PubMed ID: 1706452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleic acid binding proteins in highly purified Creutzfeldt-Jakob disease preparations.
    Sklaviadis T; Akowitz A; Manuelidis EE; Manuelidis L
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5713-7. PubMed ID: 8516321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Creutzfeld-Jakob disease: recent advances; biology of unconventional viruses (author's transl)].
    Cathala F; Moreau-Dubois MC; Brown P
    Sem Hop; 1981 Sep 8-15; 57(29-32):1338-46. PubMed ID: 6269212
    [No Abstract]   [Full Text] [Related]  

  • 11. Subcellular distribution of the transmissible agent in Creutzfeldt-Jakob disease mouse brain.
    Tamai Y; Kojima H; Ohtani Y; Uchida K; Taguchi F; Kawaguchi T; Miura S; Tateishi J
    Microbiol Immunol; 1989; 33(1):35-42. PubMed ID: 2659945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease.
    Manuelidis L; Sklaviadis T; Akowitz A; Fritch W
    Proc Natl Acad Sci U S A; 1995 May; 92(11):5124-8. PubMed ID: 7761460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of major peptides in Creutzfeldt-Jakob disease and scrapie.
    Sklaviadis T; Manuelidis L; Manuelidis EE
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6146-50. PubMed ID: 3090551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue.
    Brown P; Rohwer RG; Gajdusek DC
    J Infect Dis; 1986 Jun; 153(6):1145-8. PubMed ID: 3084671
    [No Abstract]   [Full Text] [Related]  

  • 15. Transmission and characterization of the agents of spongiform virus encephalopathies: kuru, Creutzfeldt-Jakob disease, scrapie and mink encephalopathy.
    Gibbs CJ; Gajdusek DC
    Res Publ Assoc Res Nerv Ment Dis; 1971; 49():383-410. PubMed ID: 5000225
    [No Abstract]   [Full Text] [Related]  

  • 16. Endogenous viral complexes with long RNA cosediment with the agent of Creutzfeldt-Jakob disease.
    Akowitz A; Sklaviadis T; Manuelidis L
    Nucleic Acids Res; 1994 Mar; 22(6):1101-7. PubMed ID: 8152913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creutzfeldt-Jakob disease in mice: persistent viremia and preferential replication of virus in low-density lymphocytes.
    Kuroda Y; Gibbs CJ; Amyx HL; Gajdusek DC
    Infect Immun; 1983 Jul; 41(1):154-61. PubMed ID: 6407995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of infectivity are dissociated from PrP accumulation in salivary glands of Creutzfeldt-Jakob disease agent-inoculated mice.
    Sakaguchi S; Katamine S; Yamanouchi K; Kishikawa M; Moriuchi R; Yasukawa N; Doi T; Miyamoto T
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2117-23. PubMed ID: 8409936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral amyloid in mice with Creutzfeldt-Jakob disease is influenced by the strain of the infectious agent.
    Kitamoto T; Yi R; Mohri S; Tateishi J
    Brain Res; 1990 Jan; 508(1):165-7. PubMed ID: 2186845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creutzfeldt-Jakob disease prion proteins in human brains.
    Bockman JM; Kingsbury DT; McKinley MP; Bendheim PE; Prusiner SB
    N Engl J Med; 1985 Jan; 312(2):73-8. PubMed ID: 3917302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.